Avricore Health Inc (AVCR.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 45 | 42 | 113 | 116 | 112 |
| Accounts receivable | 7 | 372 | 158 | -248 | 65 |
| Other Working Capital | -122 | 193 | -32 | -34 | -156 |
| Other Operating Activity | -337 | -387 | 108 | 407 | -9 |
| Operating Cash Flow | $-408 | $219 | $347 | $241 | $11 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -67 | -5 | -67 | -32 |
| Purchase Sale Intangibles | -4 | -16 | -7 | -1 | -9 |
| Other Investing Activity | -4 | -16 | -7 | -1 | -9 |
| Investing Cash Flow | $-6 | $-82 | $-12 | $-68 | $-40 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 18 | 53 | 1 |
| Financing Cash Flow | $0 | $0 | $18 | $53 | $1 |
| Exchange Rate Effect | -1 | 0 | 0 | N/A | N/A |
| Beginning Cash Position | 1,270 | 1,132 | 781 | 556 | 584 |
| End Cash Position | 855 | 1,270 | 1,132 | 781 | 556 |
| Net Cash Flow | $-414 | $137 | $352 | $225 | $-28 |
| Free Cash Flow | |||||
| Operating Cash Flow | -408 | 219 | 347 | 241 | 11 |
| Capital Expenditure | -6 | -82 | -12 | -68 | -40 |
| Free Cash Flow | -414 | 137 | 334 | 172 | -29 |